Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03157999Not ApplicableCompleted

Community Assets Supporting Transitions (CAST)

Role: collaborator

NCT05549375Not ApplicableCompleted

Neurorehabilitation of the Hand

Role: collaborator

NCT03451552Not ApplicableCompleted

Patient Navigation in Primary Care and Access to Resources in the Community

Role: collaborator

NCT01989962Phase 2Unknown

E4E-Health Professional Education for Improving Care for Canadian Aboriginal Populations

Role: collaborator

NCT02190227Phase 2Completed

RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment

Role: collaborator

All 5 trials loaded